Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer

Citation
Fd. Rahusen et al., Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer, ARCH SURG, 136(9), 2001, pp. 1059-1063
Citations number
41
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
ARCHIVES OF SURGERY
ISSN journal
00040010 → ACNP
Volume
136
Issue
9
Year of publication
2001
Pages
1059 - 1063
Database
ISI
SICI code
0004-0010(200109)136:9<1059:PFFMIO>2.0.ZU;2-S
Abstract
Background: The potential morbidity of an axillary lymph node dissection in patients with breast cancer can be avoided in patients with a negative sen tinel node (SN). Hypothesis: It may be possible to identify a subset of patients with a posi tive SN and without metastases in the remaining axillary lymph nodes. Design: Case-control study. Setting: Both primary and referral hospital care Patients: Data were studied for 255 consecutive patients with stage T1 or T 2 breast cancer who had a successful identification of the SN. Interventions: In patients with a positive SN, histological examination of all non-SNs that were negative by routine examination was the same as that for SNs (multiple sectioning and immunohistochemical analysis). Main Outcome Measures: The incidence of non-SN metastases was correlated wi th the surface area and number of SN metastases and primary tumor character istics. A micrometastasis was defined as less than 1 mm(2). Results: Of 255 patients, the SN appeared to be positive in 93 (36%). Subse quent axillary lymph node dissection revealed positive non-SNs in 46 patien ts (49%). Patients with a single positive SN and patients with metastases l ess than 1 mm(2) in the SN had significantly less non-SN involvement than p atients with more than 1 positive SN (40% vs 78%) and patients with macrome tastases (27% vs 49%). Conclusions: The incidence of non-SN metastases seemed to be related to the number of positive SNs and the size of SN metastases. However, in the grou p of patients with a positive SN, it was not possible to identify a subset of patients without non-SN metastases.